首页> 美国卫生研究院文献>other >A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize
【2h】

A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize

机译:一个保守的氨基酸残基作为Mdm2和MdmX RING域二聚能力差异的关键上下文特定决定因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mdm2 and MdmX are related proteins serving in the form of the Mdm2 homodimer or Mdm2/MdmX heterodimer as an E3 ubiquitin ligase for the tumor suppressor p53. The dimerization is required for the E3 activity and is mediated by the conserved RING domains present in both proteins, but only the RING domain of Mdm2 can form homodimers efficiently. We performed a systematic mutational analysis of human Mdm2, exchanging parts of the RING with the corresponding MdmX sequence, to identify the molecular determinants of this difference. Mdm2 can also promote MdmX degradation, and we identified several mutations blocking it. They were located mainly at the Mdm2/E2 interface and did not disrupt the MdmX-Mdm2 interaction. Surprisingly, some mutations of the Mdm2/E2 interface inhibited MdmX degradation, which is mediated by the Mdm2/MdmX heterodimer, but did not affect p53 degradation, mediated by the Mdm2 homodimer. Only one mutant, replacing a conserved cysteine 449 with asparagine (C449N), disrupted the ability of Mdm2 to dimerize with MdmX. When we introduced the cysteine residue into the corresponding site in MdmX, the RING domain became capable of forming dimers with other MdmX molecules in vivo, suggesting that one conserved amino acid residue in the RINGs of Mdm2 and MdmX could serve as the determinant of the differential ability of these domains to form dimers and their E3 activity. In immunoprecipitations, however, the homodimerization of MdmX could be observed only when the asparagine residue was replaced with cysteine in both RINGs. This result suggested that heterocomplexes consisting of one mutated MdmX RING with cysteine and one wild-type MdmX RING with asparagine might be less stable, despite being readily detectable in the cell-based assay. Moreover, Mdm2 C449N blocked Mdm2-MdmX heterodimerization but did not disrupt the ability of Mdm2 homodimer to promote p53 degradation, suggesting that the effect of the conserved cysteine and asparagine residues on dimerization was context-specific. Collectively, our results indicate that the effects of individual exchanges of conserved residues between Mdm2 and MdmX RING domains might be context-specific, supporting the hypothesis that Mdm2 RING homodimers and Mdm2-MdmX heterodimers may not be entirely structurally equivalent, despite their apparent similarity.
机译:Mdm2和MdmX是相关蛋白,以Mdm2同型二聚体或Mdm2 / MdmX异二聚体的形式发挥作用,作为抑癌p53的E3泛素连接酶。二聚化是E3活性所必需的,并由两种蛋白质中均存在的保守RING域介导,但只有Mdm2的RING域才能有效形成同型二聚体。我们对人Mdm2进行了系统的突变分析,将RING的一部分与相应的MdmX序列交换,以鉴定这种差异的分子决定因素。 Mdm2也可以促进MdmX降解,我们发现了几种阻止它的突变。它们主要位于Mdm2 / E2界面,并且不会破坏MdmX-Mdm2交互。出人意料的是,Mdm2 / E2接口的某些突变抑制了MdmX降解,该降解是由Mdm2 / MdmX异二聚体介导的,但不影响p53降解,而是由Mdm2同二聚体介导的。只有一个突变体用天冬酰胺(C449N)取代了一个保守的半胱氨酸449(C449N),破坏了Mdm2与MdmX二聚的能力。当我们将半胱氨酸残基引入MdmX的相应位点时,RING结构域能够在体内与其他MdmX分子形成二聚体,这表明Mdm2和MdmX的RING中一个保守的氨基酸残基可以作为差异分子的决定因素。这些结构域形成二聚体的能力及其E3活性。然而,在免疫沉淀中,只有当两个RING中的天冬酰胺残基被半胱氨酸替代时,才能观察到MdmX的二聚化。该结果表明,尽管在基于细胞的测定中很容易检测到,但由一个带有半胱氨酸的突变MdmX RING和一个带有天冬酰胺的野生型MdmX RING组成的杂合物可能不太稳定。此外,Mdm2 C449N阻断了Mdm2-MdmX异二聚化作用,但并未破坏Mdm2同二聚体促进p53降解的能力,这表明保守的半胱氨酸和天冬酰胺残基对二聚化的影响是特定于上下文的。总的来说,我们的结果表明,Mdm2和MdmX RING域之间保守残基的单个交换所产生的影响可能是特定于上下文的,从而支持了Mdm2 RING同二聚体和Mdm2-MdmX异二聚体尽管表面上相似但可能并不完全等同的假说。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号